Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for the production of (4s)-3, 4-dihydroxy-2,6, 6-trimethyl-cyclohex-2-enone and derivatives thereof

A technology of derivatives and hydroxyl, which is applied to the preparation of (4S)-3 by using the phenylethanol dehydrogenase of Azotoxabacterium, which can solve the problems of unsuitable industrial scale implementation and uneconomical

Inactive Publication Date: 2009-09-16
BASF AG
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0018] The described methods of introducing two chiral centers into one precursor for the synthesis of S,S'-astaxanthin are complex and multistage tasks or uneconomical tasks, so that it seems that these methods are hardly suitable for industrial scale implement

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for the production of (4s)-3, 4-dihydroxy-2,6, 6-trimethyl-cyclohex-2-enone and derivatives thereof
  • Method for the production of (4s)-3, 4-dihydroxy-2,6, 6-trimethyl-cyclohex-2-enone and derivatives thereof
  • Method for the production of (4s)-3, 4-dihydroxy-2,6, 6-trimethyl-cyclohex-2-enone and derivatives thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0088] Embodiment 1: Preparation of recombinant phenyl alcohol dehydrogenase

[0089] In a 100ml Erlenmeyer flask (baffle), Escherichia coli (E.coli) LU11558 prepared as described in WO 2005 / 108590 Examples 1 and 2 was dissolved in 20ml of LB-Amp / Spec / Cm (100 μg / l ampicillin Penicillin, 100 μg / l spectinomycin, 20 μg / l chloramphenicol), 0.1 mM IPTG, 0.5 g / L rhamnose, cultured at 37°C for 18 hours, and then cultured at 5000 * g for 10 min with 10 mM TRIS * Wash once with HCl (pH 7.0) and resuspend in 2 ml of the same buffer.

[0090] Cell-free crude protein extracts were prepared by disrupting E. coli LU11558 cell paste with 0.7 ml glass beads (d = 0.5 mm) in a vibrating ball mill (3 x 5 min, cooled on ice at intervals).

Embodiment 2

[0091] Example 2: Determination of the activity of the recombinant dehydrogenase obtained from Escherichia coli LU11558

[0092] 10 μl of cell-free crude extract (Example 1; approximately 10 mg / ml total protein) was shaken and incubated in 770 μl of 50 mM potassium phosphate buffer (with 1 mM MgCl 2 , pH 6.5), 100 μl of isopropanol, 100 μl of NADH solution (0.5M) and 20 μl of compound 1 (1M in DMSO). The mixture was analyzed analogously to Example 3. On average 0.13 mM of 3,4-dihydroxy-2,6,6-trimethylcyclohex-2-enone was formed. There was no detectable conversion in control experiments in which rhamnose was not added during incubation.

Embodiment 3

[0093] Embodiment 3: analysis compound 1 and compound 2

[0094] Precursor and product concentrations can be determined by HPLC. In addition to concentration, ee can also be determined based on the choice of stationary and mobile phases.

[0095] Stationary phase: Chiralpak AS-RH, 150*4.6mm, Daicel, equilibrated at 40°C

[0096] Mobile Phase: Eluent A: 10mM KH 2 PO 4

[0097] Eluent B: CH 3 CN

[0098] Gradient: Time [min] A[%] B[%] Flow rate [mL / min]

[0099] 0 90 10 0.5

[0100] 10 90 10 0.5

[0101] 11 60 40 0.5

[0102] 20 60 40 0.5

[0103] Flow rate: 0.5ml / min

[0104] Detection: UV detection at 260 nm

[0105] Dwell time:

[0106] (+)-3,4-dihydroxy-2,6,6-trimethylcyclohex-2-enone: about 9.3 minutes

[0107] (-)-3,4-dihydroxy-2,6,6-trimethylcyclohex-2-enone: about 9.8 minutes

[0108] 2-Hydroxy-3,5,5-trimethylcyclohex-2-ene-1,4-dione: about 17.6 minutes

[0109] Using authentic materi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for production of optically active (4S)-4-hydroxy-2,6,6-trimethyl-cyclohex-2-ene-1-one derivatives of formula (I) and a method for production of (3S, 3'S)-astaxanthine of formula (III) including the above method.

Description

technical field [0001] The invention relates to a method for preparing optically active (4S)-4-hydroxyl-2,6,6-trimethylcyclohex-2-en-1-one derivatives of formula (I) and (3S) of formula (III) , 3'S)-astaxanthin method, the latter method includes the former method. [0002] Background technique [0003] Since astaxanthin (3,3'-dihydroxy-β,β'-carotene-4,4'-dione) has two chiral centers at positions 3 and 3', it can be isomerized in the following configuration The body forms exist: (3S, 3'S), (3R, 3'R), (3S, 3'R) and (3R, 3'S). The two configurational isomers mentioned later are identical and represent the meso form (Carotenoids Handbook, 2004, Main List No. 405). [0004] All three forms can be found in natural sources (Carotenoids Handbook, 2004, MainList Nos. 404, 405, 406). Total chemical synthesis starting with racemic precursors yields a 1:2:1 mixture of (3S,3′S)-astaxanthin, meso-astaxanthin, and (3R,3′R)-astaxanthin (The EFSA Journal, 2005, 291, 12, Deutsche Lebe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12P23/00C12N9/04
CPCC12P7/02C12P23/00
Inventor M·布罗伊尔H·恩斯特B·豪尔
Owner BASF AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products